Back to BMRN overview

BMRN Biomarin Pharmaceutical PE ratio, current and historical analysis

As of Jun 20, 2024, the Biomarin Pharmaceutical stock's PE ratio is 77.72. This results from the current EPS of $1.09 and stock price of $84.71. The P/E ratio has a decrease of 34% from the past four quarters average of 117.5.

BMRN PE ratio history

How has BMRN's PE ratio performed in the past

The PE ratio of Biomarin Pharmaceutical has averaged 211.22 over the last five years. The current PE ratio of 77.72 is 63% below the historical average. Over the past five years, BMRN's PE ratio was at its highest in the Sep 2021 quarter at 1,288.17, when the stock price was $77.29 and the EPS was $0.06. The lowest value was in the Sep 2020 quarter, when it reached 16.15 with a price of $76.08 and an EPS of $4.71.

Average
211.22
Median
134.1
Minimum
16.15
Maximum
1,288.17

Biomarin Pharmaceutical PE ratio by year

Maximum annual decrease: -20.44% in 2023

Year PE ratio Change
2023 108.34 -20.44%
2022 136.17 N/A
2021 N/A N/A
2020 18.58 N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

BMRN average PE ratio chart

What is the average PE ratio of BMRN for the past years

BMRN's current P/E ratio is below the 3, 5 and 10-year averages.

3-year avg
274.24
5-year avg
211.22
10-year avg
211.22
15-year avg
164.38

BMRN PE vs peers

What is BMRN's PE ratio compared to its peers

Compared to its peer stock CPRX, BMRN's PE ratio stands higher.

Stock name PE ratio Market cap
CPRX Catalyst Pharmaceuticals Inc 25.98 $1.84B
BMRN Biomarin Pharmaceutical Inc 76.82 $15.9B
RARE Ultragenyx Pharmaceutical Inc N/A $3.29B
SGMO Sangamo Therapeutics Inc N/A $93.26M
FOLD Amicus Therapeutics Inc N/A $2.99B
ESPR Esperion Therapeutics Inc N/A $414.92M

Frequently asked questions

What is Biomarin Pharmaceutical's PE ratio?

The price to earnings ratio for BMRN stock as of Jun 20, 2024, stands at 77.72.

What is the 3-year average PE ratio for Biomarin Pharmaceutical (BMRN)?

The 3-year average PE ratio for BMRN stock is 274.24.

What is the 5-year average PE ratio for Biomarin Pharmaceutical (BMRN)?

The 5-year average PE ratio for BMRN stock is 211.22.

What is the highest PE ratio for BMRN?

Over the last five years, the quarterly PE ratio reached a historic high of 1,288.17 in the Sep 2021 quarter.

How does the current PE ratio for BMRN compare to its historical average?

BMRN's price to earnings ratio is currently 63% below its 5-year historical average.

Why is Biomarin Pharmaceutical's PE ratio so high?

BMRN's PE ratio of 77.72 is considered high because the company's stock price is trading at a higher multiple of earnings.

How is BMRN's PE ratio calculated (Biomarin Pharmaceutical PE ratio formula)?

To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Jun 20, 2024), Biomarin Pharmaceutical's stock price is $84.71. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $1.09. Therefore, Biomarin Pharmaceutical's P/E ratio for today is 77.72. PE RATIO(77.72) = STOCK PRICE($84.71) / TTM EPS($1.09)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.